Michihide Tokuhira

6PUBLICATIONS
26CO-AUTHORS
Medical mycologyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 03, 2026
Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

|Oct 02, 2025
Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM database.

Michihide Tokuhira, Hitomi Nakayama, Kohtaro Toyama

|May 02, 2023
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.

Michihide Tokuhira, Yuta Kimura, Takayuki Tabayashi

|Aug 09, 2020
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.

Yoshitoyo Kagami, Kazuhito Yamamoto, Taro Shibata

|Dec 19, 2019
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas.

Yuka Tanaka, Shuji Momose, Takayuki Tabayashi

|Feb 15, 2018
Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase.

Michihide Tokuhira, Yuta Kimura, Keiji Sugimoto

Pageof 1

Frequent Collaborators

1 joint publications

Yuka Tanaka

1 joint publications

Shuji Momose

1 joint publications

Yoshitoyo Kagami

1 joint publications

Kazuhito Yamamoto